See also this year's filing and all EDGAR filings for this company.
PDF Report 0001678660_2023_Prelude_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001678660, Prelude Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 204,380,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,908,000 |
| 3 | remainder_Assets | 11,212,000 |
| 4 | LiabilitiesCurrent | 21,702,000 |
| 5 | LiabilitiesNoncurrent | 3,361,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 30,651,000 |
| 9 | ResearchAndDevelopmentExpense | 92,889,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 8,102,000 |
| 13 | remainder_ComprehensiveNetIncome | -981,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 220,500,000 |
| 1 | Liabilities | 25,063,000 |
| 2 | Expenses | 123,540,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 195,437,000 |
| 5 | NetIncome | -115,438,000 |
| 6 | ComprehensiveNetIncome | -115,928,500 |
| 7 | BaseVar | 189,093,000 |
| 8 | EconomicCapitalRatio | 1.79 |
Edgar->Model Mapping
Feature Distribution
Change over Time
